Published in Arterioscler Thromb Vasc Biol on April 01, 2000
Synthesis and characterization of hybrid hyaluronic acid-gelatin hydrogels. Biomacromolecules (2013) 0.96
Surface-modified hyaluronic acid hydrogels to capture endothelial progenitor cells. Soft Matter (2010) 0.90
Covalent linkage of heparin provides a stable anti-coagulation surface of decellularized porcine arteries. J Cell Mol Med (2009) 0.85
Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules (2007) 0.83
No-reflow phenomenon and endothelial glycocalyx of microcirculation. Biochem Res Int (2011) 0.80
Pyrrole-hyaluronic acid conjugates for decreasing cell binding to metals and conducting polymers. Acta Biomater (2010) 0.78
Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody. Tissue Eng Part A (2014) 0.78
Dextran grafting on PTFE surface for cardiovascular applications. Biomatter (2014) 0.75
Effects of hyaluronic acid on bleeding following third molar extraction. J Appl Oral Sci (2017) 0.75
Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20). Curr Oncol Rep (2017) 0.75
Recent advances to accelerate re-endothelialization for vascular stents. J Tissue Eng (2017) 0.75
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med (2000) 2.52
Vitamins C and E inhibit O2- production in the pig coronary artery. Circulation (1997) 2.14
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med (1997) 2.09
Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A (1996) 2.08
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation (1989) 2.07
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation (2000) 2.07
Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation (1986) 1.99
Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation (1993) 1.98
The NMR multi-transmit phased array: a Cartesian feedback approach. J Magn Reson (2004) 1.93
Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line. J Physiol (1997) 1.92
Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up. Circulation (1992) 1.89
Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res (1998) 1.88
Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation (1997) 1.83
Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Engl J Med (1987) 1.80
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76
Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol (1998) 1.72
Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation (1995) 1.66
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65
Experimental acute thrombotic stroke in baboons. Stroke (1987) 1.64
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54
Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res (1998) 1.53
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation (1988) 1.52
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation (1990) 1.52
In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation (1985) 1.52
p38 kinase is activated in the Alzheimer's disease brain. J Neurochem (1999) 1.50
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation (1991) 1.47
Strategies for improving minority healthcare quality. Evid Rep Technol Assess (Summ) (2004) 1.46
Intracoronary beta-radiation exacerbates long-term neointima formation in balloon-injured pig coronary arteries. Circulation (2001) 1.46
Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol (1992) 1.44
Value of coronary bypass surgery. Controversies in cardiology: Part I. Am J Cardiol (1978) 1.44
Usefulness of coronary angioplasty in asymptomatic patients. Am J Cardiol (1990) 1.42
Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model. Thromb Haemost (2012) 1.42
Results of coronary surgery after failed elective coronary angioplasty in patients with prior coronary surgery. J Am Coll Cardiol (1990) 1.42
Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach. Circulation (1983) 1.40
Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother (1992) 1.40
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. Circulation (1991) 1.38
Task force 2: application of medical and surgical interventions near the end of life. J Am Coll Cardiol (1998) 1.38
Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim Biophys Acta (2001) 1.37
Surgical revascularization following unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1982) 1.36
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation (1993) 1.34
Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol (1992) 1.28
High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes (2000) 1.27
Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Am J Cardiol (2001) 1.25
Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys (2000) 1.23
Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem (2001) 1.22
Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. J Am Coll Cardiol (1987) 1.19
Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood (1985) 1.18
Efficacy of a new angioplasty catheter for severely narrowed coronary lesions. J Am Coll Cardiol (1988) 1.16
An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab (2012) 1.15
Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. J Lab Clin Med (1989) 1.14
Risk of side branch occlusion during coronary angioplasty. Am J Cardiol (1984) 1.13
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation (1984) 1.13
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry (2000) 1.12
Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation (1998) 1.12
Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol (1995) 1.11
Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol (1995) 1.11
Expression and structural analysis of 14-3-3 proteins. J Mol Biol (1995) 1.11
Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother (1990) 1.10
Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty. The International Society and Federation of Cardiology and the World Health Organization. Circulation (1988) 1.10
Oligomerization and phase separation in globular protein solutions. Biophys Chem (1998) 1.10
Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol (1993) 1.10
The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys (1996) 1.09
A mechanistic model of acute platelet accumulation in thrombogenic stenoses. Ann Biomed Eng (2001) 1.08
Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol (1995) 1.08
Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood (1989) 1.08
Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Database Syst Rev (2001) 1.08
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med (2000) 1.08
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J Am Coll Cardiol (2000) 1.06
Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J (1989) 1.06
Repeat coronary angioplasty. J Am Coll Cardiol (1984) 1.06
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res (1997) 1.06
Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem (1996) 1.05
Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1986) 1.04
Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am J Pathol (1989) 1.04
Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation (1993) 1.03
ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology. J Am Coll Cardiol (1998) 1.03
Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation (1987) 1.02
Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle. J Clin Invest (1991) 1.01
Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol (1995) 1.00
In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis. J Lab Clin Med (1980) 1.00
A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation (1995) 1.00
Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty. A prospective randomized study. Circulation (1988) 1.00
Alterations of phasic coronary artery flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol (1992) 1.00
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis (1985) 0.99
Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene (2013) 0.99
Efficacy of coronary artery bypass grafting in elderly patients with coronary artery disease. Am J Cardiol (1981) 0.98